Motilal Oswal recommends buy on Apollo Hospitals with ₹10,400 target
Business
Motilal Oswal is bullish on Apollo Hospitals, recommending a buy with a target price of ₹10,400.
This comes after Apollo's latest quarterly results beat expectations, thanks mainly to strong performances from its hospital and Healthco divisions, which helped APHS beat EBITDA and PAT estimates.
Apollo Health and Lifestyle beat estimates
Apollo Health and Lifestyle (AHLL) saw profits higher than expected even though revenue was a bit lower.
Motilal Oswal values Apollo using a mix of methods that highlight its solid position in hospitals and online pharmacy.
Analysts see plenty of room for growth and consider Apollo an attractive investment for the future.